Home > Insider Trading > Filing (0000950170-24-012354)

Filing Details

Accession Number:: 0000950170-24-012354
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-02-07 17:50:17
Reporting Period:: 2024-02-05

Accepted Time:: 2024-02-07 17:50:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
31791	Revvity Inc.	RVTY	Laboratory Analytical Instruments (3826)	042052042

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1440132	S Joel Goldberg	940 Winter Street Waltham MA 02451-1457	Please See Remarks	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-02-05	22,613	$52.65	53,500	No	4	M	Direct
Common Stock	Disposition	2024-02-05	11,546	$104.08	41,954	No	4	S	Direct
Common Stock	Disposition	2024-02-05	3,662	$104.80	38,292	No	4	S	Direct
Common Stock	Disposition	2024-02-05	267	$105.66	38,025	No	4	S	Direct
Common Stock	Acquisiton	2024-02-05	6,294	$105.62	44,319	No	4	M	Direct
Common Stock	Disposition	2024-02-05	1,909	$105.62	42,410	No	4	F	Direct
Common Stock	Disposition	2024-02-05	675	$105.62	41,735	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	NQ Stock Option (right to buy)	Disposition	2024-02-05	22,613	$0.00	22,613	$52.65
Common Stock	NQ Stock Option (right to buy)	Acquisiton	2024-02-05	27,528	$0.00	27,528	$104.64

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2024-02-07	No	4	M	Direct
27,528		2031-02-05	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	63,709	Indirect	By Goldberg Irrevocable 2021 Trust

Footnotes

The transactions reported above in Table I include a cashless exercise of stock options. The cashless exercise for the stock options is reported in four lines. The first line of the cashless exercise transaction is coded M in column 3 of Table I and reports in column 4 the number of shares issuable upon exercise of the options had cash been paid to exercise the options, together with the exercise price with Code A for acquired. The second, third, and fourth lines coded S in column 3 of Table I relate to the same cashless exercise on the first line in Table I and report in Column 4 the number of shares sold from the total number of shares issuable to pay for the cashless exercise of such options with Code D for disposed. The transaction reported in Table II line one above,
(Continued Form Footnote 1) reflects the disposition of the same stock options whose cashless exercise is disclosed in Table I above. The foregoing transactions were effected pursuant to a 10b5-1 trading plan adopted by Mr. Goldberg on August 3, 2023.
The Exercise Price included on the Form 4 filed on February 8, 2017 for the Reporting Person was incorrectly reported due to administrative error.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $103.57 to $104.56. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $104.57 to $105.47. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $105.62 to $105.68. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
Shares of common stock issued upon vesting of performance-based restricted stock units in accordance with the terms of a Performance-based Restricted Stock Unit award originally granted on February 5, 2021.
These shares are being surrendered to satisfy a tax withholding obligation upon vesting of performance-based restricted stock units originally granted on February 5, 2021, as required by the Reporting Person's Performance-based Restricted Stock Unit Agreement.
These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 5, 2021, as required by the Reporting Person's Restricted Stock Agreement.
Securities held in an irrevocable trust for the sole benefit of the reporting person's children. The reporting person's spouse is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
This option became exercisable in three equal annual installments beginning on February 7, 2018, which was the first anniversary of the date on which the option was granted.
This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.